| (1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin | multiple interactions | ISO | RGD:1605735 | 6480464 | 5-methoxy-1-methyl-2-(n-propylamino)tetralin binds to and results in decreased activity of DRD3 protein | CTD | PMID:10728880 |
| (S)-amphetamine | increases expression | ISO | RGD:735750 | 6480464 | Dextroamphetamine results in increased expression of DRD3 mRNA | CTD | PMID:18681898 |
| (S)-colchicine | decreases expression | EXP | | 6480464 | Colchicine results in decreased expression of DRD3 mRNA | CTD | PMID:7878047 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of DRD3 mRNA | CTD | PMID:12008023 |
| acrylamide | affects binding | ISO | RGD:1605735 | 6480464 | Acrylamide analog binds to DRD3 protein | CTD | PMID:15185375 |
| amitriptyline | increases expression | EXP | | 6480464 | Amitriptyline results in increased expression of DRD3 mRNA | CTD | PMID:21820738 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of DRD3 mRNA | CTD | PMID:16483693 |
| amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of DRD3 protein; more ... | CTD | PMID:12711089 |
| amphetamine | increases response to substance | EXP | | 6480464 | DRD3 protein results in increased susceptibility to Amphetamine | CTD | PMID:12711089 |
| apomorphine | increases response to substance | ISO | RGD:735750 | 6480464 | DRD3 protein results in increased susceptibility to Apomorphine | CTD | PMID:19497322 |
| baclofen | decreases expression | EXP | | 6480464 | Baclofen results in decreased expression of DRD3 mRNA | CTD | PMID:7878047 |
| bisphenol A | multiple interactions | ISO | RGD:735750 | 6480464 | bisphenol A inhibits the reaction [3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to DRD3 protein]; more ... | CTD | PMID:15203435 |
| bisphenol A | decreases activity | ISO | RGD:735750 | 6480464 | bisphenol A results in decreased activity of DRD3 protein | CTD | PMID:16045194 |
| bromocriptine | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with Bromocriptine] results in decreased expression of DRD3 mRNA | CTD | PMID:17000468 |
| bromocriptine | decreases expression | EXP | | 6480464 | Bromocriptine results in decreased expression of DRD3 mRNA | CTD | PMID:17000468 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of DRD3 mRNA | CTD | PMID:19167457 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| calcium atom | increases phosphorylation | EXP | | 6480464 | Calcium results in increased phosphorylation of DRD3 protein | CTD | PMID:19217379 |
| calcium(0) | increases phosphorylation | EXP | | 6480464 | Calcium results in increased phosphorylation of DRD3 protein | CTD | PMID:19217379 |
| clozapine | affects response to substance | ISO | RGD:1605735 | 6480464 | DRD3 protein affects the susceptibility to Clozapine | CTD | PMID:20029384 |
| clozapine | multiple interactions | ISO | RGD:735750 | 6480464 | DRD3 protein affects the reaction [Clozapine results in increased expression of FOSB protein alternative form] | CTD | PMID:15579174 |
| clozapine | decreases response to substance | ISO | RGD:1605735 | 6480464 | DRD3 gene polymorphism results in decreased susceptibility to Clozapine | CTD | PMID:20029384 |
| cocaine | increases expression | ISO | RGD:735750 | 6480464 | Cocaine results in increased expression of DRD3 mRNA | CTD | PMID:12099907 |
| cocaine | multiple interactions | ISO | RGD:735750 | 6480464 | DRD3 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; more ... | CTD | PMID:10943692 |
| cocaine | multiple interactions | ISO | RGD:735750 | 6480464 | DRD3 protein affects the reaction [Cocaine results in increased expression of NTS mRNA] | CTD | PMID:11120399 |
| cocaine | affects response to substance | ISO | RGD:735750 | 6480464 | DRD3 affects the susceptibility to Cocaine | CTD | PMID:20456009 |
| cocaine | multiple interactions | ISO | RGD:735750 | 6480464 | Cocaine promotes the reaction [DRD3 protein results in decreased expression of PDYN protein]; more ... | CTD | PMID:15056714 |
| cocaine | multiple interactions | ISO | RGD:735750 | 6480464 | [3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol co-treated with Cocaine] affects the localization of DRD3 protein; more ... | CTD | PMID:18566292 |
| cocaine | affects response to substance | ISO | RGD:1605735 | 6480464 | DRD3 affects the susceptibility to Cocaine | CTD | PMID:10523822 |
| cocaine | decreases expression | ISO | RGD:1605735 | 6480464 | Cocaine results in decreased expression of DRD3 protein | CTD | PMID:19723785 |
| cocaine | decreases response to substance | EXP | | 6480464 | DRD3 results in decreased susceptibility to Cocaine | CTD | PMID:16026479 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of DRD3 mRNA | CTD | PMID:16026479 |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of DRD3 protein | CTD | PMID:19046384 |
| cocaine | multiple interactions | EXP | | 6480464 | Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]; more ... | CTD | PMID:19217379 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of DRD3 protein | CTD | PMID:20435100 |
| cocaine | affects activity | EXP | | 6480464 | Cocaine affects the activity of DRD3 protein | CTD | PMID:15100700 |
| cocaine | decreases response to substance | ISO | RGD:735750 | 6480464 | DRD3 protein results in decreased susceptibility to Cocaine | CTD | PMID:10943692 |
| cocaine | multiple interactions | EXP | | 6480464 | 7-hydroxy-2-N,N-dipropylaminotetralin inhibits the reaction [Cocaine affects the activity of DRD3 protein] | CTD | PMID:15100700 |
| copper atom | multiple interactions | EXP | | 6480464 | Copper inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| copper(0) | multiple interactions | EXP | | 6480464 | Copper inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| dieldrin | increases expression | EXP | | 6480464 | Dieldrin results in increased expression of DRD3 mRNA | CTD | PMID:18812211 |
| dopamine | increases activity | EXP | | 6480464 | Dopamine results in increased activity of DRD3 protein | CTD | PMID:19046384 |
| dopamine | multiple interactions | EXP | | 6480464 | [Raclopride binds to and results in decreased activity of DRD3 protein] which results in increased abundance of Dopamine | CTD | PMID:15341276 |
| dopamine | multiple interactions | EXP | | 6480464 | DRD3 protein promotes the reaction [Dopamine results in increased phosphorylation of MAPK1 protein]; more ... | CTD | PMID:19217379 |
| ethanol | affects response to substance | ISO | RGD:735750 | 6480464 | DRD3 protein affects the susceptibility to Ethanol | CTD | PMID:19096829 |
| fluoxetine | multiple interactions | ISO | RGD:1605735 | 6480464 | DRD3 protein results in increased susceptibility to [olanzapine co-treated with Fluoxetine] | CTD | PMID:20021991 |
| FPL 64176 | multiple interactions | EXP | | 6480464 | FPL 64176 promotes the reaction [CAMK2A protein binds to DRD3 protein]; more ... | CTD | PMID:19217379 |
| gold atom | multiple interactions | EXP | | 6480464 | Gold inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| gold(0) | multiple interactions | EXP | | 6480464 | Gold inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| haloperidol | affects binding | ISO | RGD:1605735 | 6480464 | DRD3 protein binds to Haloperidol analog | CTD | PMID:14552778 |
| ionomycin | multiple interactions | EXP | | 6480464 | [Ionomycin co-treated with CAMK2A protein] inhibits the reaction [DRD3 protein promotes the reaction [Dopamine results in increased phosphorylation of MAPK1 protein]]; more ... | CTD | PMID:19217379 |
| ionomycin | increases phosphorylation | EXP | | 6480464 | Ionomycin results in increased phosphorylation of DRD3 protein | CTD | PMID:19217379 |
| mercury atom | multiple interactions | EXP | | 6480464 | Mercury inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| mercury(0) | multiple interactions | EXP | | 6480464 | Mercury inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| methamphetamine | decreases expression | ISO | RGD:1605735 | 6480464 | Methamphetamine results in decreased expression of DRD3 protein | CTD | PMID:19940168 |
| methamphetamine | increases activity | EXP | | 6480464 | Methamphetamine results in increased activity of DRD3 protein | CTD | PMID:19046384 |
| methylmercury chloride | decreases expression | ISO | RGD:735750 | 6480464 | methylmercuric chloride results in decreased expression of DRD3 mRNA | CTD | PMID:21385734 |
| mirtazapine | multiple interactions | EXP | | 6480464 | mirtazapine inhibits the reaction [Quinpirole binds to DRD3 protein] | CTD | PMID:12523492 |
| N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of DRD3 mRNA | CTD | PMID:17000468 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with Bromocriptine] results in decreased expression of DRD3 mRNA | CTD | PMID:17000468 |
| N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol | multiple interactions | EXP | | 6480464 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [SK&F 83959 promotes the reaction [CAMK2A protein binds to DRD3 protein]]; more ... | CTD | PMID:19217379 |
| nifedipine | multiple interactions | EXP | | 6480464 | Nifedipine inhibits the reaction [FPL 64176 promotes the reaction [CAMK2A protein binds to DRD3 protein]] | CTD | PMID:19217379 |
| olanzapine | multiple interactions | ISO | RGD:1605735 | 6480464 | DRD3 protein results in increased susceptibility to [olanzapine co-treated with Fluoxetine] | CTD | PMID:20021991 |
| pramipexole | multiple interactions | ISO | RGD:1605735 | 6480464 | pramipexol binds to and results in increased activity of DRD3 protein | CTD | PMID:10728880 |
| risperidone | increases response to substance | ISO | RGD:1605735 | 6480464 | DRD3 gene SNP results in increased susceptibility to Risperidone | CTD | PMID:19506579 |
| risperidone | increases response to substance | ISO | RGD:1605735 | 6480464 | DRD3 protein results in increased susceptibility to Risperidone | CTD | PMID:19997080 |
| ropinirole | multiple interactions | ISO | RGD:1605735 | 6480464 | ropinirole binds to and results in increased activity of DRD3 protein | CTD | PMID:18242171 PMID:18393062 |
| ropinirole | multiple interactions | ISO | RGD:1605735 | 6480464 | ropinirole binds to and results in increased activity of DRD3 protein | CTD | PMID:18393062 PMID:18242171 |
| silver atom | multiple interactions | EXP | | 6480464 | Silver inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| silver(0) | multiple interactions | EXP | | 6480464 | Silver inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |
| zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] | CTD | PMID:10215675 |